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Abstract
 
The steps involved in lymphocyte homing to the white pulp cords of the spleen are poorly un-
derstood. We demonstrate here that the integrins lymphocyte function associated (LFA)-1 and
 
 
 
4
 
 
 
1 make essential and mostly overlapping contributions necessary for B cell migration into
white pulp cords. T cell entry to the white pulp is also reduced by blockade of LFA-1 and
 
 
 
4
 
 
 
1. The LFA-1 ligand, intercellular adhesion molecule 1 is critical for lymphocyte entry and
both hematopoietic cells and radiation-resistant cells contribute to this requirement. Vascular
 
cell adhesion molecule 1 contributes to the 
 
 
 
4
 
 
 
1 ligand requirement and a second ligand,
possibly fibronectin, also plays a role. By contrast with the entry requirements, antigen-induced
movement of B cells from follicles to the outer T zone is not prevented by integrin blocking
antibodies. Comparison of the distribution of integrin-blocked B cells and B cells treated with
the G
 
 
 
i inhibitor, pertussis toxin, early after transfer reveals in both cases reduced accumulation
in the inner marginal zone. These observations suggest that chemokine receptor signaling and
the integrins LFA-1 and 
 
 
 
4
 
 
 
1 function together to promote lymphocyte transit from the mar-
ginal zone into white pulp cords.
Key words: splenic white pulp • LFA-1 • 
 
 
 
4
 
 
 
1 • lymphocyte homing • marginal zone
 
Introduction
 
The spleen is a major secondary lymphoid tissue important
in host protection against many types of pathogen, espe-
cially encapsulated bacteria (1). The lymphoid regions of
the spleen, known as white pulp cords, are organized into
inner T cell zones and outer B cell follicles. The follicular
areas associated with large white pulp cords are surrounded
by a region termed the marginal zone, which consists of
loosely associated B cells, macrophages, and reticular cells
and forms the border between the white pulp and the red
pulp (2). Many small follicular arterioles terminate in the
marginal zone in a region known as the marginal sinus
whereas a smaller number of penicillar arterioles terminate
directly in the red pulp (3, 4). Although there is some con-
troversy regarding whether a marginal sinus exists in the
human spleen, corrosion casting experiments established
that large amounts of blood are released into sinuses present
within the marginal zone in all species examined, including
humans and rodents (4, 5). Many of the lymphocytes en-
tering the spleen are released in the marginal zone (6–8).
Some of these cells, together with the nonlymphocytes,
pass to the outer region of the marginal zone and then to
the red pulp or directly into venous sinuses. A fraction of
the lymphocytes take a different route and quickly begin
appearing within the B and T cell areas of the white pulp
cords (7, 8).
Extensive studies of the molecular mechanisms controlling
lymphocyte entry into lymph nodes and Peyer’s patches
have established a cascade model of entry. First, lympho-
cytes undergo rolling interactions, principally mediated by
L-selectin binding to ligands on the high endothelial
venules (HEVs;
 
*
 
 references 9 and 10). Subsequently, a che-
mokine-mediated triggering event occurs that causes inte-
grin activation and adhesion. LFA-1 (
 
 
 
L
 
 
 
2 or CD11a/
CD18), 
 
 
 
4
 
 
 
7, and 
 
 
 
4
 
 
 
1 contribute to differing extents to
this integrin adhesion requirement (10, 11).
Despite the detailed understanding of the steps involved
in lymphocyte entry to lymph nodes and Peyer’s patches,
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Abbreviations used in this paper: 
 
AP, alkaline phosphatase; CFSE, 5(and 6)-
carboxyfluorescein diacetate succinimidyl ester; HEL, hen egg lysozyme;
HEV, high endothelial venule; HRP, horseradish peroxidase; ICAM, in-
tercellular adhesion molecule; MAdCAM, mucosal addressin cell adhesion
molecule; PTX, pertussis toxin; VCAM, vascular cell adhesion molecule.T
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relatively little is known about how the cells enter white
pulp cords in the spleen (12, 13). In particular, whether in-
tegrins are required has not been established, although
some experiments have suggested that they may not be
critical (14–16). However, our recent finding that marginal
zone B cell adhesion within the splenic marginal zone in-
volves redundant contributions by the integrins LFA-1 and
 
 
 
4
 
 
 
1 (17) led us to test the combined contribution of these
integrins in lymphocyte entry to white pulp cords.
 
Materials and Methods
 
Mice and Adoptive Cell Transfer.
 
C57BL/6 (B6) mice were
from Charles River Laboratories or a colony maintained at Uni-
versity of California San Francisco. Igh
 
a 
 
(Ig heavy chain of a)
Thy1
 
a 
 
GPI1
 
a 
 
B6 mice (termed Igh
 
a 
 
B6 mice) were from The Jack-
son Laboratory. 
 
 
 
2
 
 
 
/
 
  
 
(18), 
 
 
 
7
 
 
 
/
 
  
 
(19), and intercellular adhe-
sion molecule (ICAM)-1–deficient mice (20) were obtained on a
B6 background from The Jackson Laboratory. Ig
 
HEL
 
 transgenic
B6 mice express IgM
 
a 
 
and IgD
 
a 
 
specific for hen egg lysozyme
(HEL). Mice were treated with antibodies by intraperitoneal in-
jection in 300 uL PBS. Bone marrow chimeras were made as pre-
viously described (17). For adoptive transfers, mice were injected
with 
 
 
 
3 
 
  
 
10
 
7 
 
spleen cells in 0.3 ml medium. In some experi-
ments, cells were labeled before transfer with 5(and 6)-carboxy-
fluorescein diacetate succinimidyl ester (CFSE; Molecular Probes)
as previously described (21).
 
Antibodies and Treatments.
 
The anti-
 
 
 
L (clone M17/4, rat
IgG2a) hybridoma was from American Type Culture Collection
and the anti-
 
 
 
4 (clone PS/2, rat IgG2b) hybridoma was provided
by David Erle (University of California San Francisco, San Fran-
cisco, CA). Anti–vascular cell adhesion molecule (VCAM)-1
(clone M/K-2, rat IgG1) was obtained from Southern Biotech-
nology Associates, Inc. Anti–mucosal addressin cell adhesion
molecule (MAdCAM)-1 (clone MECA-367, rat IgG2A) and
anti-
 
 
 
1 (clone HA2/5, Armenian hamster IgM) were obtained
from BD Biosciences. Antibodies were administered intraperito-
neally at 100 (anti-
 
 
 
L and anti-
 
 
 
4) or 200 ug (anti-
 
 
 
1, anti–
MAdCAM-1, and anti–VCAM-1) doses approximately 1 h be-
fore intravenous cell transfer unless otherwise indicated. Cells
were treated with PBS, 200 ng/ml oligomer B (List Biologicals),
or 200 ng/ml pertussis toxin (PTX; Sigma-Aldrich) as previously
described (12).
 
Flow Cytometric Analysis.
 
Transferred B cells were identified
flow cytometrically by staining for B220, IgM
 
a
 
, and IgD
 
a 
 
or
B220, IgM
 
b
 
, and IgD
 
b
 
, or in the case of CFSE-labeled cells, by
B220 staining alone. Transferred T cells were identified by stain-
ing for Thy1
 
a
 
, CD4, and CD8 or as CFSE-labeled CD3
 
  
 
cells.
Integrin saturation (anti-
 
 
 
L and anti-
 
 
 
4) on transferred and en-
dogenous cells was detected by isolating splenocytes from anti-
body-treated animals and adding anti–rat-IgG PE (Jackson Im-
munoResearch Laboratories) directly to the cells or after
incubation with excess of the anti-integrin antibodies to achieve
in vitro saturation. Splenocytes from a PBS-treated animal served
as the negative control. Analysis 1 h after antibody injection
showed that endogenous spleen cells were saturated with the in-
tegrin-neutralizing antibodies.
 
Immunohistochemical Analysis and Cell Enumeration.
 
5–7-
 
 
 
m
cryostat sections were fixed and stained as previously described
(21) using the following antibodies: rat anti–IgM
 
a
 
-biotin, IgD
 
a
 
-
biotin, B220-FITC, Thy1
 
a
 
-biotin, IgM
 
b
 
-biotin or FITC, IgD
 
b
 
-
biotin or FITC, MAdCAM-1 (BD Biosciences), rabbit anti–rat
 
fibronectin (Invitrogen), and rabbit anti–HEL-biotin (Rockland
Immunochemicals). Rat IgG antibodies were detected using
streptavidin alkaline phosphatase (AP), anti-FITC horseradish
peroxidase (HRP), or anti–rat HRP. Rabbit IgG antibodies were
detected using anti–rabbit HRP or streptavidin AP. Triple stain-
ing for IgM
 
b 
 
plus IgD
 
b
 
, HEL, and MAdCAM-1 was accom-
plished by staining for IgM
 
b
 
-FITC plus IgD
 
b
 
-FITC and MAd-
CAM-1 as described above, heat inactivating the AP at 65
 
 
 
C for
15 min, and then proceeding to stain for HEL. Enzyme reactions
were developed with conventional substrates for peroxidases (di-
aminobenzidine/H
 
2
 
O
 
2
 
; Sigma-Aldrich) and AP (Fast Blue/Fast
Red; Sigma-Aldrich). Cell enumeration was performed by locat-
ing well-defined B220-stained white pulp cords (follicular areas
encompassing a central T zone) and counting transferred B or T
cells within at least three (mostly five to eight) white pulp cords
per mouse. For experiments tracking WT cells in control, anti-
body-treated, or ICAM-1
 
 
 
/
 
  
 
recipients, Igh
 
a 
 
B6 donor cells were
used and transferred B cells were identified using a combination
of anti-IgM
 
a 
 
and anti-IgD
 
a 
 
antibodies. For experiments with 
 
 
 
2
 
 
 
/
 
 
 
and 
 
 
 
7
 
 
 
/
 
  
 
donors, Igh
 
a 
 
B6 recipients were used and transferred
cells were identified by using a combination of anti-IgM
 
b 
 
and
anti-IgD
 
b 
 
antibodies. In some transfers of WT Igh
 
a 
 
cells to B6 re-
cipients, T cells were identified using anti-Thy1
 
a 
 
antibodies, but
in many cases this approach was unsuccessful due to diffusion of
the stain. Additional T cell enumeration data was obtained by
transfer of AUTOMACS (Miltenyi)-purified CFSE-labeled T
cells and detecting the T cells with anti-FITC AP. Statistical anal-
ysis was performed using Student’s 
 
t
 
 test.
 
Results and Discussion
 
LFA-1 and 
 
 
 
4
 
 
 
1 Function in B and T Cell Entry to the
Splenic White Pulp.
 
To test the possibility that LFA-1 and
 
 
 
4-containing integrins make overlapping contributions to
lymphocyte entry into the splenic white pulp, WT mice
were treated with a combination of LFA-1–and 
 
 
 
4 block-
ing antibodies and the subsequent trafficking of transferred
lymphocytes was examined. Strikingly, in mice given the
combined treatment, B cell entry to white pulp cords was
reduced by 
 
 
 
90% (Fig. 1, A and C) and T cell entry was
reduced by 50% (Fig. 1 B). As expected (17), the combined
antibody treatment also led to displacement of marginal
zone B cells from around the white pulp cords (Fig. 1, A
and B) whereas marginal metallophilic macrophages and
marginal zone macrophages were not displaced (unpub-
lished data). The total number of transferred lymphocytes
in the spleen was not greatly affected by the antibody treat-
ment whereas entry into lymph nodes was strongly inhib-
ited (Fig. 1 C), as expected (10, 11). The lack of an effect
on total spleen cell numbers despite the inhibition in cell
entry to white pulp cords is similar to the previous findings
for cells treated with PTX (12) and most likely reflects the
presence of greater numbers of cells in the red pulp due to
the lymphocytosis caused by the block in entry to lymph
nodes. Analysis of the effect of blocking LFA-1 alone re-
vealed 
 
 
 
50% inhibition in white pulp accumulation of B
cells (Fig. 1 C) and 
 
 
 
30% inhibition for T cells (not de-
picted). In a recent study, cells from LFA-1–deficient mice
were reported to show a small (
 
 
 
20%) reduction in lym-
phocyte homing to white pulp cords (16). The differencesT
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.
in the extent of inhibition observed might reflect our direct
enumeration of cells within white pulp cords versus Nolte
et al.’s (22) approach of measuring cells flow cytometrically
in enzymatically isolated spleen preparations enriched for
white pulp cord cells. Treatment with 
 
 
 
4 blocking anti-
bodies alone had no measurable effect on the number of B
or T lymphocytes accumulating in the white pulp over the
3-h period (Fig. 1). Thus, the contribution of 
 
 
 
4-contain-
ing integrins to lymphocyte homing to the white pulp
appears to be fully redundant to LFA-1 whereas the contri-
bution of LFA-1 is partially redundant with the 
 
 
 
4-con-
taining integrins.
As B cell homing was more strongly inhibited by inte-
grin neutralization than T cell homing, we focused our
Figure 1. LFA-1 and  4 1 function in B
and T cell entry into splenic white pulp cords.
(A and B) Immunohistochemical analysis of
spleen sections from B6 mice that had received
WT Igha Thy1a spleen cells 3 h before and had
been pretreated with PBS or  L and  4 neu-
tralizing antibodies, as indicated, 1 h before cell
transfer. Transferred B cells were detected by
IgMa plus IgDa staining (A, blue), transferred T
cells by Thy1a staining (B, blue), and endoge-
nous B cells by B220 staining (brown).  5. (C)
Summary of B cell homing data showing the
average number of transferred B cells per white
pulp cross section (left), per one fifth of spleen
(middle), and in a pool of inguinal and brachial
lymph nodes (right). Donor cells were from
WT,  2 / , or  7 /  mice as indicated. Each
bar shows the average ( SD) value for data
from at least four animals of each type except
for the  2 /  and  7 /  transfers where the in-
dividual data points are denoted by  . *, P  
0.05 compared with untreated WT controls.
Similar enumeration was performed for T cells
and the following average number of cells were
detected per white pulp cord: PBS-treated,
218   11 (n   3);  4-treated, 242 (n   1);  L-
treated, 152   13 (n   3);  L plus  4-treated,
118     14 (n     4). (D and E) Immunohis-
tochemical analysis of spleen sections from WT
Igha B6 mice that had received  7 /  Ighb cells
(D) or B6 mice that had received WT Igha
spleen cells (E) and had been treated with inte-
grin neutralizing antibodies, as indicated. Trans-
ferred B cells were detected by staining IgMb
plus IgDb (D) or IgMa plus IgDa (E).T
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subsequent experiments on B cells. To further test the
contribution of  2-containing integrins and dissect the
contributions of  4 1 and  4 7 to white pulp homing of
B cells, transfer experiments were performed with spleen
cells from  2 /  (18) or  7 /   (19) mice. In the absence
of antibody treatment,  2-deficient B cells showed a two-
fold decrease in white pulp homing compared with WT
cells, consistent with the LFA-1 blocking experiments
(Fig. 1 C). When  2-deficient cells were transferred to
mice that had been pretreated with  4 blocking antibod-
ies, homing was inhibited to the same extent as in mice
treated with LFA-1 and  4 blocking antibodies (Fig. 1 C),
indicating that the few remaining cells that continue to
enter white pulp cords in LFA-1– and  4-blocked animals
was not due to incomplete neutralization of LFA-1 or to
contributions by other  2-containing integrins. Further-
more, as treatment with anti- 4 alone does not cause dis-
placement of marginal zone B cells (17), this experiment
indicates that the diminished white pulp homing is not
due to effects on marginal zone B cells. When  7-defi-
cient cells were transferred to WT mice, no defects in cell
entry to splenic white pulp cords were observed, consis-
tent with previous observations in mice treated with  4 7
blocking antibodies (15). In addition, when  7-deficient
cells were transferred to mice pretreated with anti–LFA-1,
B cell homing was no more affected than was the case for
WT cells treated with anti–LFA-1, further indicating that
 4 7 is not critical for lymphocyte trafficking into white
pulp cords (Fig. 1, C and D). This observation implicates
 4 1 as the key  4-containing integrin involved and the
finding that combined treatment with  1 and LFA-1
blocking antibodies inhibited B cell homing to white pulp
cords to the same extent as combined treatment with  4
and LFA-1 blocking antibodies confirms this conclusion
(Fig. 1, C and E).
Integrin Ligand Requirements for Lymphocyte Entry to the
White Pulp. The best-defined ligands for LFA-1 are
ICAM-1, ICAM-2, and ICAM-3 whereas key  4 1
ligands are VCAM-1, MAdCAM-1, and fibronectin (10,
23, 24). Many of the lymphocytes entering the spleen are
released in the marginal zone and ICAM-1 and VCAM-1
expression has been detected throughout this zone (5, 16,
17). MAdCAM-1 is also expressed within the marginal
zone (5) and in mice the expression is mostly limited to
cells associated with the follicular side of the marginal sinus
(15). We first tested the contribution of ICAM-1 to B cell
migration into white pulp cords by using ICAM-1–defi-
cient mice (20). B cell homing was partially reduced in
these animals and when they had been treated with anti- 4
blocking antibodies, homing was inhibited to an extent
similar to experiments in which mice were treated with a
combination of LFA-1 and  4 blocking antibodies (Fig. 2,
A and B). Analysis of  4 1 ligand involvement was per-
formed by treating mice with VCAM-1 or MAdCAM-1
blocking antibodies together with the LFA-1 neutralizing
antibody. No contribution could be identified for MAd-
CAM-1 despite the expected block in lymphocyte homing
to mucosal lymph nodes (Fig. 2 B). By contrast, inhibition
of VCAM-1 function was associated with a reduction in B
cell homing to the white pulp compared with animals
treated with LFA-1 blocking antibodies alone (Fig. 2, A
and B). However, the block in homing by the combination
of anti–VCAM-1 and anti–LFA-1 was less severe than that
observed after anti- 4 plus anti–LFA-1 treatment or anti-
 1 plus anti–LFA-1 treatment (Fig. 1), indicating that an
additional  4 1 ligand participates in B cell homing into
white pulp cords. Combined treatment with neutralizing
antibodies specific for VCAM-1, MAdCAM-1, and LFA-1
did not cause any greater inhibition than observed by
VCAM-1 and LFA-1 blocking (Fig. 2 B). Although no re-
agents are available to selectively inhibit  4 1–fibronectin
interactions in the mouse, these findings are consistent with
the possibility that fibronectin functions as an adhesion
molecule for B cell migration into white pulp cords. How-
ever, our experiments do not rule out possible contribu-
tions by other molecules that can bind  4 1, such as von
Willebrand factor and thrombospondin (24). Favoring a
role for fibronectin, immunohistochemical analysis re-
vealed that this extracellular matrix protein is expressed at a
high level throughout the marginal zone as well as in the
red pulp (Fig. 2 C). Analysis of sections double stained for
fibronectin and MAdCAM-1 indicated an overlap in the
staining pattern consistent with fibronectin being associated
with marginal sinus lining cells (Fig. 2 C). Fibronectin has
also been identified within the marginal zone of human
spleen (25).
To determine whether the ICAM-1 necessary for B cell
homing in the spleen was made by hematopoietic or non-
hematopoietic cells, radiation bone marrow chimeras were
generated. After reconstitution, these animals were treated
with  4 blocking antibodies and then transferred with WT
lymphocytes (Fig. 2). For reasons that are unclear, the
homing of B cells to white pulp cords in control bone mar-
row chimeras (WT bone marrow → WT recipients) was
reduced compared with homing in nonirradiated WT con-
trols (Fig. 2 D), indicating that there was some alteration in
B cell trafficking due to the effects of irradiation. However,
compared with this control group, homing in ICAM-1–
deficient chimeras (ICAM-1 /  bone marrow → ICAM-
1 /  recipients) was severely inhibited (Fig. 2 D). By con-
trast, in mice where ICAM-1 expression was restricted to
radiation-resistant cells (ICAM-1 /  bone marrow → WT
recipients), B cell entry to white pulp cords was only
weakly reduced compared with the WT controls. Simi-
larly, when ICAM-1 expression was restricted to radiation-
sensitive hematopoietic cells (WT bone marrow → ICAM-
1 /  recipients), homing was only weakly affected (Fig. 2
D). Therefore, the ICAM-1 requirement for B cell homing
into splenic white pulp cords involves contributions by
both radiation-sensitive hematopoietic cells and radiation-
resistant cells. Consistent with a hematopoietic cell type
playing a role in guiding lymphocyte homing in the spleen,
ablation of marginal zone macrophages was associated with
a reduction in the efficiency of lymphocyte homing into
white pulp cords (26). The nature of the ICAM-1–express-
ing radiation-resistant cells in the marginal zone is unclearT
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Figure 2. ICAM-1 and VCAM-1 function
in B cell entry into splenic white pulp cords.
(A) Immunohistochemical analysis of spleen
sections from ICAM-1 /  or WT mice that had
received Igha B6 spleen cells 3 h before and had
been pretreated as indicated 1 h before cell
transfer. Transferred cells were detected as de-
scribed in Fig. 1.  5. (B) Summary of trans-
ferred B cell homing data showing the average
number of B cells per white pulp cross section
(left), per one fifth of spleen (middle), and the
frequency in a pool of inguinal and brachial
lymph nodes (pLN) or in mesenteric lymph
nodes (mLN) as indicated (right). Donor cells
were from WT mice and the genotype of the
recipient animals is indicated. The dashed line
in the White Pulp panel indicates the average number of transferred WT cells reaching the white pulp in untreated controls as shown in Fig. 1. *, P  
0.05 compared with untreated WT controls; **, P   0.05 compared with ICAM-1 /  or anti- L–treated mice. (C) Fibronectin expression pattern in
mouse spleen. Spleen sections from WT mice were stained to detect fibronectin alone (left, brown) or together with MAdCAM-1 (right, blue). (D)
Summary of B cell homing data in ICAM-1 /  or control bone marrow chimeras treated with  4 blocking antibody. Recipient ICAM-1 /  or WT
mice were reconstituted with ICAM-1 /  or WT bone marrow (BM), as indicated, treated with anti- 4, and transferred with WT cells. *, P   0.05
compared with WT bone marrow chimeras. Cell number was enumerated as described in Materials and Methods. Each bar shows the average ( SD)
value for data from at least four animals per group in B and three animals in D. T
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but may include the marginal sinus lining cells and marginal
zone reticular cells (2, 5, 17).
Relocalization of Antigen-engaged B Cells from Follicles to T
Zones Is Not Blocked by Integrin Neutralizing Antibodies. To
examine whether integrins are also critical for B cell
movement within the white pulp, we tested the effect of
LFA-1 and  4 blocking antibodies on the migration of
antigen-engaged B cells from follicles to the outer T zone
(21). Previous experiments have established that this re-
distribution process is complete within 6 h of antigen ex-
posure. Therefore, IgHEL transgenic B cells specific for
HEL were transferred to WT mice and after allowing 1 d
for the cells to become distributed in lymphoid follicles,
mice were treated with LFA-1 and  4 neutralizing anti-
bodies and then exposed to HEL antigen. Immunohis-
tochemical analysis of spleens isolated 6 h later demon-
strated that B cells had redistributed from the follicles to
T cell areas in a manner similar to mice that did not re-
ceive integrin blocking antibodies (Fig. 3 A). Samples of
the tissue from each animal were used to generate cell
suspensions and these were tested by flow cytometric
analysis to confirm that the integrins on both the endoge-
nous and transferred B cells were saturated by the neutral-
izing antibodies (Fig. 3 B). These findings indicate that
movement of B cells inside the splenic white pulp can oc-
cur when LFA-1 and  4 1 are blocked, favoring the
conclusion that the integrin requirement for homing into
the white pulp reflects a role during an early entry step.
Additional approaches will be needed to determine
whether integrins contribute to the basal motility of naive
lymphocytes within the white pulp and to identify what
other types of adhesive interactions are used by migrating
white pulp cells.
PTX and Integrin Blocking Antibodies Inhibit Splenic B Cell
Migration at a Similar Step. Previous experiments have
demonstrated that PTX-treated lymphocytes fail to enter
white pulp cords (12, 13). To examine whether the re-
quirements for G i signaling and integrin function occur at
a similar step, short-term transfer experiments were per-
formed in which mice received cotransfers of treated and
control cells (Fig. 4 A). At early time points after transfer of
untreated cells, many cells were present within the mar-
ginal zone and, similar to a previous report (7), a fraction of
the cells appeared on the inner (follicular) edge of the mar-
ginal zone associated with the MAdCAM-1  cells (Fig. 4
B). Comparison of the distribution of PTX-treated cells
and control cells revealed that fewer of the treated cells
were located along this boundary whereas treatment with
the inactive oligomer B subunit of PTX had no effect (Fig.
4, B, C and E). A similar analysis was attempted to test the
role of integrins at this step by transferring cells that had
been pretreated with integrin blocking antibodies together
with untreated cells, but no differences were observed in
the distribution of treated and untreated cells (unpublished
data). However, flow cytometric analysis of the pretreated
cells isolated 10 min after transfer revealed that  50% of
the surface integrins were no longer occupied by neutraliz-
ing antibody despite presaturation before transfer (not de-
picted). Therefore, we used an alternative approach where
 2-deficient and WT cells were cotransferred to mice that
had been pretreated with  4 blocking antibodies. Although
all the cells would have their  4 integrins neutralized, the
experiments described above established that this does not
measurably affect passage of WT lymphocytes into white
pulp cords (Fig. 1). Analysis of the distribution of  2 / 
versus control cells 15 min after transfer revealed a defi-
Figure 3. Inhibition of LFA-1 and  4 func-
tion does not prevent antigen-induced relocal-
ization of B cells from follicles to the outer T
zone. (A) Immunohistochemical analysis of
spleen sections from mice that had received
IgHEL transgenic B cells 1 d before, anti–LFA-1
and anti- 4 antibodies or PBS 8 h before, and 1
mg HEL antigen 6 h before. Transgenic B cells
were detected by staining for HEL binding
(blue) and endogenous B cells were detected with anti-
B220 (brown).  20. (B) Flow cytometric analysis to
detect amounts of integrin blocking antibodies on the
surface of B cells. Spleen cells from mice treated as de-
scribed in A were either directly stained with anti–rat
IgG (In vivo, red line), or after additional incubation in
vitro with saturating amounts of anti–LFA-1 and anti- 4
(In vitro, blue line), and with antibodies to detect B220
and HEL. Levels of anti–rat IgG staining on B220 
HEL  endogenous cells (left) or B220  HEL  trans-
ferred cells (right) are shown. Cells from mice that had
not been injected with anti-integrin antibodies served
as a negative control (Nil, green line).T
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ciency in  2 /  cells near the inner edge of the marginal
zone (Fig. 4, D and E). Therefore, treatment with PTX
and combined inhibition of  4 1 and LFA-1 both disrupt
attachment or accumulation of B cells on the inner side of
the marginal zone, as well as prevent their subsequent ap-
pearance within the white pulp cords.
Concluding Remarks. The findings described above
demonstrate that LFA-1 and  4 1 and their ligands play
Figure 4. PTX and integrin blocking affect B cell entry into white pulp cords at a sim-
ilar early step. (A) Mixed adoptive transfers were performed using spleen cells from WT
Ighb mice that were treated in vitro with PBS, oligomer B (Oli. B), or PTX and trans-
ferred intravenously to WT Igha recipients together with equal numbers of PBS-treated
WT IgHEL transgenic cells. Alternatively,  2 /  Ighb spleen cells were mixed with WT
IgHEL transgenic cells and transferred to anti- 4 antibody–treated recipients. 15 min after
transfer, recipient spleens were isolated and subjected to immunohistochemical analysis as
indicated. (B–D) Three color immunohistochemical analysis of spleen sections from mice
that had received a mixture of oligomer B– (B) or PTX–treated (C) spleen cells and
PBS-treated IgHEL transgenic internal control cells, or from mice that had been pretreated
with anti- 4 antibody and received a mixture of  2 /  and IgHEL transgenic cells (D).
Sections were stained for IgMb plus IgDb (blue) to detect treated or  2 /  B cells, HEL
(red) to detect IgHEL transgenic B cells, and MAdCAM-1 (brown) to highlight the
boundary between the marginal zone and white pulp. Filled arrows identify control IgHEL
B cells (red) and open arrows identify treated or  2 /  B cells (blue) in the inner mar-
ginal zone (defined by physical association with the MAdCAM-1–stained cells). WP,
white pulp.  20. (E) Summary of data showing inhibitory effect of PTX treatment and
integrin blocking on B cell localization in the inner marginal zone. Transferred cells were
identified as indicated in A and the number of cells in the inner marginal zone was enu-
merated as exemplified by the cells indicated by arrows in B–D. More than 12 separate
cross sections from each spleen were enumerated and between 2 and 4 spleens of each
type were analyzed. *, P   0.05 compared with IgHEL transgenic internal control cells.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
360 Integrin-dependent Lymphocyte Entry into Splenic White Pulp
critical roles in lymphocyte entry into the splenic white
pulp, revealing closer parallels than previously thought be-
tween this process and entry into lymph nodes and Peyer’s
patches. The integrin entry requirement is stronger for B
than T cells, and LFA-1 appears to make the dominant
contribution to the homing requirement for both cell
types. Overlapping contributions of LFA-1 and  4 1 have
previously been observed for lymphocyte attachment to
HEVs and accumulation in the bone marrow (11) and for
marginal zone B cell lodgement in the marginal zone (17).
Our findings indicate that the key ligands involved in B cell
entry are ICAM-1, VCAM-1, and a second  4 1 ligand.
As fibronectin is present in large amounts within the mar-
ginal zone, we suggest that this  4 1 ligand also contrib-
utes to the entry process. Although MAdCAM-1 is ex-
pressed in an appropriate location to participate in entry
(15), experiments using MAdCAM-1 blocking antibodies
and  7-deficient cells failed to reveal a contribution for this
adhesion molecule even when the contributions of LFA-1/
ICAM-1 were blocked. Consistent with MAdCAM-1 not
having a critical role, this ligand has not been detected in
rat spleen (27). The requirement of  4 1 and LFA-1 both
for cell entry into the white pulp and for long-term adher-
ence of cells in the marginal zone might be explained at
least in part by marginal zone B cells expressing higher lev-
els of functional integrins and adhering more strongly to
ICAM-1 and VCAM-1 than follicular cells (17). It may
also indicate that other differences between marginal zone
and follicular B cells contribute to positioning, such as dif-
ferences in chemokine responsiveness.
Although our experiments indicate that G i signaling
and integrins participate at a similar early step in white pulp
entry, we have not yet been able to determine the order of
their requirement. Our findings are consistent with the
possibility that integrins function both upstream and down-
stream of chemokine signals during the entry process. Se-
lectins do not appear to be required for lymphocyte entry
to the splenic white pulp (16) perhaps because the shear
forces operating on lymphocytes released from splenic arte-
rioles are weaker than those occurring in HEVs. However,
some tethering mechanism might be necessary to prevent
the cells from being flushed into the red pulp and  4 1
and LFA-1 may contribute to this process in a similar way
to their role in helping tether lymphocytes to mucosal
HEVs (10) and neutrophils to inflamed endothelium (28).
This step may also involve lectins (other than selectins) and
their glycoprotein ligands (15, 29). In addition, integrins
may function downstream of chemokine signals to facilitate
transit of cells from the marginal zone into the white pulp
cords. Whether this step involves passage across an endo-
thelial-type barrier is not known although it seems possible
that this is the case as the marginal sinus lining cells in the
mouse have properties similar to endothelial cells (2). Che-
mokine receptor requirements for entry into splenic folli-
cles and T zones include CXCR5 and CCR7, respectively
(see references in 10 and 21), although contributions by
other G i-coupled receptors have not been ruled out. Fi-
nally, the basis for the differing requirements of B and T
cells for LFA-1 and  4 1 to enter white pulp cords is un-
clear. In addition to entry after their release in the marginal
zone, some cells are believed to migrate to white pulp
cords after release at terminal arterioles in the red pulp (8,
30). It seems possible that the integrin requirements for en-
try by this pathway will be distinct and that T and B cells
may differ in the degree to which they use these routes to
enter the white pulp cords.
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